Key Market Indicators
Czech Antidepressant Medicine Sales are projected to hit $93 million by 2028, up from approximately $83 million in 2023. This marks an average annual growth rate of 1.5%. Since 1995, the Czech market has expanded steadily with an average yearly growth rate of 4.5%. In 2023, the Czech Republic ranked eighth globally in antidepressant sales, with Greece slightly ahead, also at around $83 million. Leading the rankings, Spain secured the second spot, followed by Italy and Australia in third and fourth places, respectively.
